knowledge -WSS

knowledge

author：Wikipedia 2025-09-27 09:38:27 - browse：254

MultiPlan is facing a new class action lawsuit that alleges the company and large health insurers “conspired to fix, suppress, and stabilize” payments made for out-of-network medical claims.

The lawsuit, filed by for-profit hospital company Allegiance Health Management, builds on the contentious relationship between hospitals and MultiPlan, a data technology vendor that works with the biggest insurers to determine how much should be paid for care that is delivered outside of an insurance network. It comes just weeks after the New York Times published an investigation detailing how MultiPlan and its insurance company clients make more money by low-balling payments to hospitals.

The lawsuit further lays bare some of the warped incentives that exist within the health care system: out-of-network providers billing inflated amounts, insurers profiting by making sure those payments are as low as possible, and patients stuck in the middle with bills they often cannot afford.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Chan Zuckerberg Biohub Chicago to focus on inflammation

WSS

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

AI can decode, harness the power of the humane immune system

Why Charlie Gard's case is so disturbing to Americans

FDA panel signals lack of confidence in Amgen cancer drug data

What to expect at HLTH 2023, the health care industry conference

VC firm General Catalyst wants to buy a health system

leisure time

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Ionis drug prevents swelling attacks due to hereditary angioedema

Moonlake's readout produced a cash windfall. Risks remain

At ASCO, AstraZeneca reports strong data for breast cancer drug

Trump demands the U.S. pay no more for drugs than other countries … again

Chemotherapy drug shortage eases slightly but still widespread

In age of alternative facts, a scholarly course on calling out crap

Woman returns to dialysis after doctors remove transplanted pig kidney

How to save PrEP access — and even expand it

VC firm General Catalyst wants to buy a health system

hotspot

ASCO: Palliative care found as helpful given virtually as in person

NIH documents show early flaws of $1.6 billion long Covid program

Analysis of telehealth claims data suggest service duplication

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Senate panel eyes new effort on drug shortages

entertainment

leisure time

Wikipedia

hotspot